News
CDER estimates the seven new RPA projects in development will save 24,000 work hours annually, including those where bots schedule meetings and assign letters. The agency has used RPA for a year with ...
3d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?The founder and former CEO of several pharmaceutical companies, Tidmarsh was tapped by FDA Commissioner Marty Makary, MD, MPH ...
Upgrading CDER’s workforce was already underway before the pandemic thanks to the FDA’s 21st Century Cures Act, which Cavazzoni called “a real godsend” and “a game-changer.” ...
Patrizia Cavazzoni is director of the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration. Billy Dunn is director of CDER’s Office of Neuroscience. Peter Stein is ...
The US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) on Tuesday released a new report on drug safety priorities from 2018, offering last year’s valsartan ...
CDER’s new Office of Pharmaceutical Quality (OPQ) will be the center’s single unit dedicated to the purpose, and will begin operations on Jan. 5, 2015.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results